ZTS:NYSE
Zoetis Inc
$71.40
arrow_downward
-2.22%(-1.62) 1D
$71.75
arrow_upward
+0.49% (+0.35)bedtimeAfter hours
Closed: Sep 18, 4:03:21 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$72.56
High
$73.05
Low
$71.40
Mkt. cap
29.50B
Avg. vol.
5.64M
Volume
9.88M
Dividend
2.97%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.75
52-wk high
$148.79
52-wk low
$71.00
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
Open
$72.56
High
$73.05
Low
$71.40
Mkt. cap
29.50B
Avg. vol.
5.64M
Volume
9.88M
Dividend
2.97%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
11.75
52-wk high
$148.79
52-wk low
$71.00
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
News stories
From web sources and news partners
Kalkine Media
·
8 hours ago
Zoetis Director Mark Stetter Acquires 342 Phantom Stock Units Under Deferred Compensation Plan
Yahoo Finance
·
9 hours ago
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
Seeking Alpha
·
17 hours ago
Zoetis Stock: The Worst May Be Priced In (NYSE:ZTS)
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com